chr13-33053623-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004795.4(KL):​c.820-144A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.29 in 774,990 control chromosomes in the GnomAD database, including 33,964 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.27 ( 5842 hom., cov: 33)
Exomes 𝑓: 0.30 ( 28122 hom. )

Consequence

KL
NM_004795.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 1.08

Publications

10 publications found
Variant links:
Genes affected
KL (HGNC:6344): (klotho) This gene encodes a type-I membrane protein that is related to beta-glucosidases. Reduced production of this protein has been observed in patients with chronic renal failure (CRF), and this may be one of the factors underlying the degenerative processes (e.g., arteriosclerosis, osteoporosis, and skin atrophy) seen in CRF. Also, mutations within this protein have been associated with ageing and bone loss. [provided by RefSeq, Jul 2008]
KL Gene-Disease associations (from GenCC):
  • tumoral calcinosis, hyperphosphatemic, familial, 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • tumoral calcinosis, hyperphosphatemic, familial, 3
    Inheritance: AR, Unknown Classification: LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 13-33053623-A-G is Benign according to our data. Variant chr13-33053623-A-G is described in ClinVar as Benign. ClinVar VariationId is 1233548.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.436 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004795.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KL
NM_004795.4
MANE Select
c.820-144A>G
intron
N/ANP_004786.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
KL
ENST00000380099.4
TSL:1 MANE Select
c.820-144A>G
intron
N/AENSP00000369442.3
KL
ENST00000487852.1
TSL:5
n.828-144A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.266
AC:
40403
AN:
151994
Hom.:
5838
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.200
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.260
Gnomad EAS
AF:
0.451
Gnomad SAS
AF:
0.331
Gnomad FIN
AF:
0.306
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.286
GnomAD4 exome
AF:
0.295
AC:
183967
AN:
622880
Hom.:
28122
AF XY:
0.296
AC XY:
96030
AN XY:
324506
show subpopulations
African (AFR)
AF:
0.201
AC:
3316
AN:
16476
American (AMR)
AF:
0.178
AC:
4798
AN:
26898
Ashkenazi Jewish (ASJ)
AF:
0.261
AC:
4166
AN:
15954
East Asian (EAS)
AF:
0.462
AC:
15579
AN:
33728
South Asian (SAS)
AF:
0.301
AC:
15934
AN:
52934
European-Finnish (FIN)
AF:
0.292
AC:
10152
AN:
34796
Middle Eastern (MID)
AF:
0.269
AC:
971
AN:
3612
European-Non Finnish (NFE)
AF:
0.295
AC:
119993
AN:
406322
Other (OTH)
AF:
0.282
AC:
9058
AN:
32160
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
6466
12932
19398
25864
32330
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2088
4176
6264
8352
10440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.266
AC:
40420
AN:
152110
Hom.:
5842
Cov.:
33
AF XY:
0.268
AC XY:
19904
AN XY:
74368
show subpopulations
African (AFR)
AF:
0.200
AC:
8292
AN:
41496
American (AMR)
AF:
0.215
AC:
3287
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.260
AC:
902
AN:
3470
East Asian (EAS)
AF:
0.451
AC:
2329
AN:
5160
South Asian (SAS)
AF:
0.331
AC:
1599
AN:
4828
European-Finnish (FIN)
AF:
0.306
AC:
3238
AN:
10576
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.291
AC:
19769
AN:
67968
Other (OTH)
AF:
0.283
AC:
598
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1475
2950
4425
5900
7375
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
434
868
1302
1736
2170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.263
Hom.:
796
Bravo
AF:
0.257
Asia WGS
AF:
0.347
AC:
1206
AN:
3478

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
6.9
DANN
Benign
0.54
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7323281; hg19: chr13-33627760; API